Journal for ImmunoTherapy of Cancer (Nov 2021)
700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy
- Peng Jiang,
- Xia Bu,
- Michael Manos,
- Ana Lako,
- Scott Rodig,
- Yingtian Xie,
- Shengqing Gu,
- Henry Long,
- Paloma Cejas,
- Gordon Freeman,
- Wubing Zhang,
- Xiaoqing Wang,
- Nicole Traugh,
- Ziyi Li,
- Clifford Meyer,
- Blair Stewig,
- Alba Font-Tello,
- Klothilda Lim,
- Jake Conway,
- Alok Tewari,
- Zexian Zeng,
- Avinash Das Sahu,
- Collin Tokheim,
- Jason Weirather,
- Jingxin Fu,
- Benjamin Kroger,
- Jin Hua Liang,
- Benjamin Gewurz,
- F. Stephen Hodi,
- Myles Brown,
- X Shirley Liu
Affiliations
- Peng Jiang
- Department of Interventional Neuroradiology, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Xia Bu
- Aff676 grid.65499.370000000121069910Dana-Farber Cancer Institute Boston MA USA
- Michael Manos
- Dana Farber Cancer Institute, Boston, Massachusetts, USA
- Ana Lako
- Bristol-Myers Squibb, Cambridge, MA, USA
- Scott Rodig
- 7Brigham and Women’s Hospital and Harvard, Boston, MA, USA
- Yingtian Xie
- 4 Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
- Shengqing Gu
- 4 Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
- Henry Long
- 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
- Paloma Cejas
- 2Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
- Gordon Freeman
- 5Dana-Farber Cancer Institute, Boston, MA, USA
- Wubing Zhang
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Xiaoqing Wang
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Nicole Traugh
- 3Tufts University, Boston, MA, United States
- Ziyi Li
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Clifford Meyer
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Blair Stewig
- 4Boston Children`s Hospital, Boston, MA, United States
- Alba Font-Tello
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Klothilda Lim
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Jake Conway
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Alok Tewari
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Zexian Zeng
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Avinash Das Sahu
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Collin Tokheim
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Jason Weirather
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Jingxin Fu
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Benjamin Kroger
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Jin Hua Liang
- 5Brigham and Women’s Hospital, Boston, MA, United States
- Benjamin Gewurz
- 6Brigham and Women`s Hospital, Boston, MA, United States
- F. Stephen Hodi
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- Myles Brown
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- X Shirley Liu
- 1Dana-Farber Cancer Institute, Boston, MA, United States
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.700
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
